Leg ulcer treatments market seen rising to $5.9 billion by 2030

The Business Research Company says the leg ulcer treatments market will grow from $4.05 billion in 2025 to $4.36 billion in 2026, then reach $5.9 billion by 2030. The report points to rising chronic wounds, aging populations and wider use of outpatient and home-based care as the main growth drivers.

Why it matters: - Chronic wounds are creating steady demand for leg ulcer treatments across hospitals, outpatient clinics and home care. - The market’s projected growth signals more spending on wound care, compression therapy and advanced dressings. - The report also points to a shift toward preventive vascular screening and standardized treatment guidelines.

What happened: - The Business Research Company released a leg ulcer treatments market report covering market size, growth drivers, regional trends and company strategy. - The market is estimated at $4.05 billion in 2025 and is forecast to reach $4.36 billion in 2026. - The report projects the market will climb to $5.9 billion by 2030. - The report says the market is growing at a 7.6% CAGR from 2025 to 2026 and a 7.8% CAGR through 2030.

The details: - Leg ulcer treatments include medical interventions for chronic wounds on the lower limbs. - The report says leg ulcers are commonly linked to venous insufficiency, arterial disease, diabetes and pressure-related injuries. - Treatment aims to speed wound healing, prevent infection, ease pain and improve blood circulation. - Common approaches include specialized dressings, compression therapy and advanced wound care techniques. - The report says market growth has been supported by rising diabetes prevalence, more peripheral vascular disease cases, limited access to advanced wound care, higher hospital admissions for chronic wounds and low awareness of early ulcer management. - The report identifies a rising incidence of chronic wounds as a key growth driver. - Chronic wounds are defined in the report as wounds that do not heal within the expected timeframe and often persist beyond three months. - Aging populations are increasing the burden because older adults face more diabetes, poor circulation and reduced skin integrity. - The report says data from NHS England in November 2023 showed 193 inpatients developed bed sores, pressure sores or pressure ulcers between October 2022 and October 2023. - North America was the largest regional market in 2025. - Asia-Pacific is projected to be the fastest-growing regional market during the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology and future trend analysis, and updated graphics and tables. - The report is available through the full market report and a free sample.

Between the lines: - The report frames leg ulcer care as a beneficiary of broader trends in aging, chronic disease and outpatient treatment. - Its emphasis on home-based management and preventive screening suggests growing pressure to treat wounds earlier and outside acute-care settings. - The regional outlook implies mature demand in North America and faster expansion where healthcare spending and elder populations are rising.

What's next: - The report expects demand to keep rising as more patients need long-term wound management. - Wider use of compression and debridement therapies is likely as clinical guidelines continue to standardize care. - The market will likely track investments in outpatient services, home care and advanced wound management tools.